Akebia Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Akebia Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Akebia Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 212M shares, a 12.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 212M +23.2M +12.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 210M +21.8M +11.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 209M +23.6M +12.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 195M +10.4M +5.67% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 188M +4.36M +2.37% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 188M +4.42M +2.41% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 186M +2.45M +1.34% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 184M +7.13M +4.03% Dec 31, 2022 10-K 2024-03-14
Q3 2022 184M +9.4M +5.39% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 184M +14.1M +8.28% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 183M +24.9M +15.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 177M +28.9M +19.5% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 175M +31.2M +21.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 170M +26.5M +18.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 159M +28.3M +21.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 148M +26.4M +21.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 143M +24.5M +20.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 143M +24.3M +20.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 130M +13.1M +11.2% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 122M +4.79M +4.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 119M +61.8M +108% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 119M +61.9M +109% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 117M +60.3M +106% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 117M +69.3M +145% Dec 31, 2018 10-K 2020-03-12
Q3 2018 57M +9.81M +20.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 56.9M +14.4M +33.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 56.9M +18M +46.4% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 47.6M +9M +23.3% Dec 31, 2017 10-K 2019-03-26
Q3 2017 47.2M +8.98M +23.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 42.5M +4.48M +11.8% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 38.8M +884K +2.33% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 38.6M +7.95M +25.9% Dec 31, 2016 10-K 2018-03-12
Q3 2016 38.3M +8.04M +26.6% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 38M +9.13M +31.6% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 37.9M +17.5M +85.3% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 30.7M +10.3M +50.5% Dec 31, 2015 10-K 2017-03-06
Q3 2015 30.2M +9.92M +48.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 28.9M +8.62M +42.5% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 20.5M +211K +1.04% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 20.4M +19M +1373% Dec 31, 2014 10-K 2016-03-14
Q3 2014 20.3M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 20.3M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 20.3M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 1.38M Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.